Quvium Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Series A
  • (Cancelled)
  • Latest Deal Amount
  • $4.2M
Latest Deal Amount
  • Investors
  • 6

Quvium General Information

Description

Developer of a medical device designed to assist people with chronic and acute respiratory conditions. The company's device which is a wearable cough monitor predicts and prevent attacks or flare-ups, reducing emergency room visits, hospitalizations and even deaths, enabling asthma sufferers, as well as cystic fibrosis patients and people with chronic obstructive pulmonary disease, get access to better treatment and enhanced medical care.

Contact Information

Formerly Known As
Asthma Signals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Therapeutic Devices
Primary Office
  • Unit 4/5 Invicta Way
  • Manston Park
  • Ramsgate CT12 5FD
  • England, United Kingdom
+44 01304 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quvium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) $4.2M Cancelled Generating Revenue
5. Later Stage VC 05-Apr-2019 00000 00.00 00.00 Completed Generating Revenue
4. Early Stage VC 11-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
3. Grant 03-Nov-2017 00000 00.000 Completed Generating Revenue
2. Early Stage VC 23-Nov-2016 $1.68M $2.08M 00.000 Completed Generating Revenue
1. Equity Crowdfunding 22-Jun-2015 $400K $400K 00.000 Completed Generating Revenue
To view Quvium’s complete valuation and funding history, request access »

Quvium Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 79,700 $0.000001 $4.12 $4.12 1x $4.12 5.01%
Ordinary 81,600 $0.000001 $4.85 $4.85 1x $4.85 5.13%
To view Quvium’s complete cap table history, request access »

Quvium Patents

Quvium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2536699-A Cough detection, analysis, and communication platform Withdrawn 26-Mar-2015 0000000000 0
GB-201505214-D0 Cough detection, analysis, and communication platform Withdrawn 26-Mar-2015 0000000000
GB-201412909-D0 Cough detection, analysis, and communication platform Granted 22-Jul-2013 0000000000
GB-201601781-D0 Cough detection, annalysis,and communication platform Ceased 22-Jul-2013 0000000000
GB-2516768-A Cough detection, analysis, and communication platform Granted 22-Jul-2013 A61B5/0823 0
To view Quvium’s complete patent history, request access »

Quvium Executive Team (3)

Name Title Board Seat Contact Info
Steven Schmidt Co-Founder, Chief Executive Officer & Board Member
Thomas Smith Co-Founder & President
Karen Travers Co-Founder & CCO
To view Quvium’s complete executive team members history, request access »

Quvium Board Members (10)

Name Representing Role Since
Christopher Hare Quvium Board Member 000 0000
David Bell Quvium Board Member 000 0000
Gill Inman Quvium Board Member 000 0000
Mark Murcko Ph.D Self Board Member 000 0000
Peng Wu Quvium Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Quvium Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quvium Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GrowthInvest Angel Group Minority 000 0000 000000 0
NCL Technology Ventures Venture Capital Minority 000 0000 000000 0
Vala Capital Venture Capital Minority 000 0000 000000 0
Creative UK Venture Capital Minority 000 0000 000000 0
Expansion East Kent Other 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »